The director of the MedStar Georgetown University Hospital Headache Center shares her experience as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
“I came away from this meeting with a much better understanding of some of these newer treatment options, how they compare to options that I grew up with, and when it might be a good time to pull out one of the newer treatment options. I really came out with some fresh data.”
Jessica Ailani, MD, director of the MedStar Georgetown University Hospital Headache Center, served as a migraine cochair at the 2022 International Congress on the Future of Neurology (IFN) annual meeting, held September 23-24, in New York City. She mentioned that serving as the chair offered her and colleagues a great opportunity to ponder on what they want to hear about as neurologists.
The conference featured the latest information on topics in neurology, including updates on multiple sclerosis and antiseizure medications for epilepsy. One of Ailani’s bigger takeaways from the meeting was getting a greater understanding of when to explore newer treatment options. She also mentioned that it was nice to be surrounded by a diverse group of speakers, noting that the field is growing to be even more diverse.
In a recent conversation with NeurologyLive®, Ailani discussed her experience at the IFN annual meeting and her takeaways from participating in the event. She said that she felt that the conference brings insight to the audience and centers more around the patient experience. Additionally, she also spoke about looking forward to seeing how the conference will evolve over the next several years and how the experience might change in both the in-person and virtual aspects.